Caris Initiates Coverage on Spectranetics (SPNC) with an Average
Caris initiates coverage on Spectranetics (Nasdaq: SPNC) with an Average. Price target $5.
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system for use with Spectranetics' excimer laser system.
Related Categories
New CoverageStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
